TIMP2 and colorectal carcinoma: Although more recombinant TIMP‐2 was added to the culture medium of cell lines, the small molecule inhibitor LY2784544 could still act on the downstream JAK–STAT signalling pathway to sensitise CRC cells to 5‐Fu.